Multiparametric MR Imaging for Detection of Clinically Significant Prostate Cancer: A Validation Cohort Study with Transperineal Template Prostate Mapping as the Reference Standard
Authors:
- Hashim U. AhmedHAHashim U. Ahmed
- Caroline M. MooreCMCaroline M. Moore
- Alex FreemanAFAlex Freeman
- Clare AllenCAClare Allen
- S. Aslam SohaibSSS. Aslam Sohaib
- Alex KirkhamAKAlex Kirkham
- Jan van der MeulenJMJan van der Meulen
- Mark EmbertonMEMark Emberton
- 1 September 2013
- journal article
- research article
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 268 (3) , 761-769
Abstract
The combination of an observed negative predictive value of up to 95% for clinically significant prostate cancers (dependent on cancer burden defined on the reference test) and a negative likelihood ratio as low as 0.2 indicates that multiparametric MR imaging may be useful to rule out clinically significant prostate cancer. PurposeTo evaluate the diagnostic performance of multiparametric (MP) magnetic resonance (MR) imaging for prostate cancer detection by using transperineal template prostate mapping (TTPM) biopsies as the reference standard and to determine the potential ability of MP MR imaging to identify clinically significant prostate cancer.Materials and MethodsInstitutional review board exemption was granted by the local research ethics committee for this retrospective study. Included were 64 men (mean age, 62 years [range, 40–76]; mean prostate-specific antigen, 8.2 ng/mL [8.2 μg/L] [range, 2.1–43 ng/mL]), 51 with biopsy-proved cancer and 13 suspected of having clinically significant cancer that was biopsy negative or without prior biopsy. MP MR imaging included T2-weighted, dynamic contrast-enhanced and diffusion-weighted imaging (1.5 T, pelvic phased-array coil). Three radiologists independently reviewed images and were blinded to results of biopsy. Two-by-two tables were derived by using sectors of analysis of fo...Keywords
This publication has 39 references indexed in Scilit:
- Suitability of PSA-detected localised prostate cancers for focal therapy: experience from the ProtecT studyBritish Journal of Cancer, 2011
- Characterizing Clinically Significant Prostate Cancer Using Template Prostate Mapping BiopsyJournal of Urology, 2011
- The Role of 3-Dimensional Mapping Biopsy in Decision Making for Treatment of Apparent Early Stage Prostate CancerJournal of Urology, 2011
- Advancements in MR Imaging of the Prostate: From Diagnosis to InterventionsRadioGraphics, 2011
- A Critical Analysis of the Tumor Volume Threshold for Clinically Insignificant Prostate Cancer Using a Data Set of a Randomized Screening TrialJournal of Urology, 2011
- Transperineal prostate biopsy: analysis of a uniform core sampling pattern that yields data on tumor volume limits in negative biopsiesTheoretical Biology and Medical Modelling, 2010
- Performance of transperineal template-guided mapping biopsy in detecting prostate cancer in the initial and repeat biopsy settingProstate Cancer and Prostatic Diseases, 2009
- Gleason Score and Lethal Prostate Cancer: Does 3 + 4 = 4 + 3?Journal of Clinical Oncology, 2009
- Multiparametric magnetic resonance imaging in prostate cancer: present and futureCurrent Opinion in Urology, 2008
- Comparative accuracy: assessing new tests against existing diagnostic pathwaysBMJ, 2006